Changing Mortality Profile among HIV-Infected Patients in Rio de Janeiro, Brazil: Shifting from AIDS to Non-AIDS Related Conditions in the HAART Era

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Grinsztejn, Beatriz ^a   Luz, Paula M ^a   Pacheco, Antonio G ^b   Santos, Desiree V G ^a   Velasque, Luciane ^a,c   Moreira, Ronaldo I ^a   Guimarães, Maria Regina C ^a   Nunes, Estevão P ^a   Lemos, Alberto S ^a   Ribeiro, Sayonara R ^a   Campos, Dayse P ^a   Vitoria, Marco A A ^d   Veloso, Valdilea G ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ALGORITHM; ARTICLE; BRAZIL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CONGENITAL DISORDER; DIABETES MELLITUS; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; MOTOR NEURON DISEASE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PANCREATITIS; PNEUMONIA; PROPORTIONAL HAZARDS MODEL; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE; SEPSIS; SKIN DISEASE; SUBSTANCE ABUSE; UROGENITAL TRACT DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; TEMPORAL ARTERIES; YOUNG ADULT;

EID: 84875917351     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059768     Document Type: Article

References (32)

1. ART-CC (2010) Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clinical Infectious Diseases 50: 1387-1396.
2. Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, et al. (2006) Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of the Acquired Immunodeficiency Syndrome 41: 194-200.
3. Pacheco AG, Tuboi SH, Faulhaber JC, Harrison LH, Schechter M, (2008) Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS One 3: e1531.
4. Pacheco AG, Tuboi SH, May SB, Moreira LF, Ramadas L, et al. (2009) Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. Journal of the Acquired Immunodeficiency Syndrome 51: 624-630.
5. Grinsztejn B, Veloso VG, Friedman RK, Moreira RI, Luz PM, et al. (2009) Early mortality and cause of deaths in patients using HAART in Brazil and the United States. AIDS 23: 2107-2114.
6. Grinsztejn B, Veloso VG, Pilotto JH, Campos DP, Keruly JC, et al. (2007) Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil. J Acquir Immune Defic Syndr 45: 515-520.
7. Moreira RI, Luz PM, Struchiner CJ, Morgado M, Veloso VG, et al. (2011) Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore. J Acquir Immune Defic Syndr 57 (Suppl 3): S171-178.
8. Pacheco AG, Saraceni V, Tuboi SH, Moulton LH, Chaisson RE, et al. (2008) Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil. American Journal of Epidemiology 168: 1326-1332.
9. Smith C, (2010) Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 24: 1537-1548.
10. Sackoff JE, Hanna DB, Pfeiffer MR, Torian LV, (2006) Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Annals of Internal Medicine 145: 397-406.
11. Egger M, May M, Chene G, Phillips AN, Ledergerber B, et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360: 119-129.
12. Phillips A, Pezzotti P, (2004) Short-term risk of AIDS according to current CD4 cell count and viral load in antiretroviral drug-naive individuals and those treated in the monotherapy era. AIDS 18: 51-58.
13. Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, et al. (2012) All-cause mortality in treated HIV-infected adults with CD4>/ = 500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 41: 433-445.
14. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med 171: 1560-1569.
15. Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, et al. (2011) When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med 154: 509-515.
16. Kitahata MM, Gange SJ, Abraham AG, Merriman B, Saag MS, et al. (2009) Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360: 1815-1826.
17. Sterne JA, May M, Costagliola D, de Wolf F, Phillips AN, et al. (2009) Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373: 1352-1363.
18. Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, et al. (2012) Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy. AIDS 26: 315-323.
19. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
20. Smit C, Geskus R, Walker S, Sabin C, Coutinho R, et al. (2006) Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion. AIDS 20: 741-749.
21. WHO (2012) WHO policy on collaborative TB/HIV activities: guidelines for national programmes and other stakeholders. World Health Organization website. Available: http://whqlibdocwhoint/publications/2012/9789241503006_engpdf. Accessed 2013 Mar 10. Switzerland: World Health Organization.
22. Japiassu AM, Amancio RT, Mesquita EC, Medeiros DM, Bernal HB, et al. (2010) Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Critical Care 14: R152.
23. Martinson NA, Karstaedt A, Venter WD, Omar T, King P, et al. (2007) Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS 21: 2043-2050.
24. Lichtenstein KA, Armon C, Buchacz K, Chmiel JS, Buckner K, et al. (2010) Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clinical Infectious Diseases 51: 435-447.
25. Triant VA, Regan S, Lee H, Sax PE, Meigs JB, et al. (2010) Association of Immunologic and Virologic Factors With Myocardial Infarction Rates in a US Healthcare System. Journal of the Acquired Immunodeficiency Syndrome.
26. Lang S, Mary-Krause M, Simon A, Partisani M, Gilquin J, et al. (2012) HIV Replication and Immune Status Are Independent Predictors of the Risk of Myocardial Infarction in HIV-Infected Individuals. Clin Infect Dis 55: 600-607.
27. Simard EP, Engels EA, (2010) Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis 51: 957-962.
28. Diamond C, Taylor TH, Im T, Anton-Culver H, (2006) Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS. Leuk Lymphoma 47: 1822-1829.
29. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, et al. (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123: 187-194.
30. Bohlius J, Schmidlin K, Costagliola D, Fatkenheuer G, May M, et al. (2009) Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy. AIDS 23: 2029-2037.
31. Kowalska JD, Friis-Moller N, Kirk O, Bannister W, Mocroft A, et al. (2011) The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology 22: 516-523.
32. Schramm JMA, Oliveira AF, Leite IC, Valente JG, Gadelha AJ, et al. (2004) Epidemiological transition and the study of burden of disease in Brazil. Ciencia e Saude Coletiva 9: 897-908.